Ken Shirabe

20PUBLICATIONS
85CO-AUTHORS
Innate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 02, 2026
CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.

|Aug 28, 2026
Achievement of the Ideal Outcome After Pancreatectomy for Pancreatic Ductal Adenocarcinoma Is Associated With Earlier Initiation and Higher Completion Rates of Adjuvant Chemotherapy and Improved Long-Term Survival.

|Aug 04, 2026
Impact of Histopathological Response on Outcomes After Surgical Resection Following Carbon-Ion Radiotherapy for Pancreatic Cancer With Arterial Involvement.

|Aug 03, 2026
Hospital Volume and Operative Mortality in Pancreaticoduodenectomy and Hepatectomy: Analysis of the National Clinical Database in Japan.

|Jul 28, 2026
Prediction of Long-Term Prognosis in Patients With Hepatocellular Carcinoma Using the National Clinical Database Risk Calculator.

|Jul 24, 2026
Systematic Review and Meta-Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma.

Pageof 4

Frequent Collaborators

6 joint publications

Kenichiro Araki

5 joint publications

Makoto Sakai

4 joint publications

Takamichi Igarashi

4 joint publications

Hideki Ueno